Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Oncology
Join Editorial Board Propose a Special Issue
Print ISSN: 1019-6439 Online ISSN: 1791-2423
Journal Cover
November-2014 Volume 45 Issue 5

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2014 Volume 45 Issue 5

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Overexpression of integrin αv facilitates proliferation and invasion of oral squamous cell carcinoma cells via mek/erk signaling pathway that is activated by interaction of integrin αvβ8 with type Ⅰ collagen

  • Authors:
    • Yasutaka Hayashido
    • Hisataka Kitano
    • Taishi Sakaue
    • Takahiko  Fujii
    • Mirei Suematsu
    • Shigeru Sakurai
    • Tetsuji Okamoto
  • View Affiliations / Copyright

    Affiliations: Department of Molecular Oral Medicine and Maxillofacial Surgery, Division of Frontier Medical Science, Graduate School of Biomedical Sciences, Hiroshima University, Minami‑ku, Hiroshima 734‑8553, Japan, Department of Oral Surgery, Nihon University Itabashi Hospital, Itabashi‑ku, Tokyo 173‑8610, Japan, Department of Molecular Oral Medicine and Maxillofacial Surgery, Division of Frontier Medical Science, Graduate School of Biomedical Sciences, Hiroshima University, Minami‑ku, Hiroshima 734‑8553, Japan
  • Pages: 1875-1882
    |
    Published online on: September 4, 2014
       https://doi.org/10.3892/ijo.2014.2642
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

To examine the role of integrin αv subunit in the progression of squamous cell carcinoma (SCC), oral SCC cells were stably transfected with integrin αv cDNA. Integrin αv transfectants exhibited the enhancement of proliferation on type Ⅰ collagen, and seemed to have a high ability to invade type Ⅰ collagen gel. Overexpression of integrin αv led to rapid phosphorylation of focal adhesion kinase (FAK), mitogen‑activated protein kinase kinase 1/2 (MEK1/2) and extracellular signal‑regulated kinase 1/2 (ERK1/2) in SCC cells on type Ⅰ collagen. The downregulation of integrin β8 in integrin αv transfectants by its specific antisense oligonucleotide led to a decrease in type Ⅰ collagen‑stimulated activation of FAK and the MEK/ERK signaling pathway, and also suppressed the proliferation on type Ⅰ collagen and the invasiveness into type Ⅰ collagen gel. Moreover, the expression of integrin β8 was induced following transfection with integrin αv cDNA. These results indicated that the overexpression of integrin αv induces integrin αvβ8 heterodimer formation and the binding of integrin αvβ8 to type Ⅰ collagen might enhance the proliferation and invasion of SCC cells via the activation of the MEK/ERK signaling pathway.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Bosman FT, de Bruïne A, Flohil C, van der Wurff A, ten Kate J and Dinjens WW: Epithelial-stromal interactions in colon cancer. Int J Dev Biol. 37:203–211. 1993.PubMed/NCBI

2 

Ziober BL, Lin CS and Kramer RH: Laminin-binding integrins in tumor progression and metastasis. Semin Cancer Biol. 7:119–128. 1996. View Article : Google Scholar : PubMed/NCBI

3 

Chrenek MA, Wong P and Weaver VM: Tumour-stromal interactions. Integrins and cell adhesions as modulators of mammary cell survival and transformation. Breast Cancer Res. 3:224–229. 2001. View Article : Google Scholar : PubMed/NCBI

4 

Labat-Robert J: Fibronectin in malignancy. Semin Cancer Biol. 12:187–195. 2002. View Article : Google Scholar

5 

Huang CY, Lee CY, Chen MY, et al: Stromal cell-derived factor-1/CXCR4 enhanced motility of human osteosarcoma cells involves MEK1/2, ERK and NF-kappaB-dependent pathways. J Cell Physiol. 221:204–212. 2009. View Article : Google Scholar : PubMed/NCBI

6 

Hynes RO: Integrins: bidirectional, allosteric signaling machines. Cell. 110:673–687. 2002. View Article : Google Scholar : PubMed/NCBI

7 

Barczyk M, Carracedo S and Gullberg D: Integrins. Cell Tissue Res. 339:269–280. 2010. View Article : Google Scholar

8 

Takada Y, Ye X and Simon S: The integrins. Genome Biol. 8:2152007. View Article : Google Scholar : PubMed/NCBI

9 

Howe A, Aplin AE, Alahari SK and Juliano RL: Integrin signaling and cell growth control. Curr Opin Cell Biol. 10:220–231. 1998. View Article : Google Scholar : PubMed/NCBI

10 

Dedhar S: Cell-substrate interactions and signaling through ILK. Curr Opin Cell Biol. 12:250–256. 2000. View Article : Google Scholar : PubMed/NCBI

11 

Schwartz MA and Assoian RK: Integrins and cell proliferation: regulation of cyclin-dependent kinases via cytoplasmic signaling pathways. J Cell Sci. 114:2553–2560. 2001.PubMed/NCBI

12 

Hood JD and Cheresh DA: Role of integrins in cell invasion and migration. Nat Rev Cancer. 2:91–100. 2002. View Article : Google Scholar : PubMed/NCBI

13 

Chung J and Mercurio AM: Contributions of the α6 integrins to breast carcinoma survival and progression. Mol Cells. 17:203–209. 2004.

14 

Gleason B, Adley B, Rao MS and Diaz LK: Immunohistochemical detection of the β4 integrin subunit in pancreatic adenocarcinoma. J Histochem Cytochem. 53:799–801. 2005.

15 

Valea FA, Haskill S, Moore DH and Fowler WC Jr: Immunohistochemical analysis of α1-integrins in cervical cancer. Am J Obstet Gynecol. 173:808–813. 1995.

16 

Boudjadi S, Carrier JC and Beaulieu JF: Integrin α1 subunit is up-regulated in colorectal cancer. Biomark Res. 1:162013.

17 

Bartolazzi A, Cerboni C, Flamini G, Bigotti A, Lauriola L and Natali PG: Expression of α3β1 integrin receptor and its ligands in human lung tumors. Int J Cancer. 64:248–252. 1995.

18 

Goldberg I, Davidson B, Reich R, et al: αv integrin expression is a novel marker of poor prognosis in advanced-stage ovarian carcinoma. Clin Cancer Res. 7:4073–4079. 2001.

19 

Davidson B, Goldberg I, Reich R, et al: αv- and β1-integrin subunits are commonly expressed in malignant effusions from ovarian carcinoma patients. Gynecol Oncol. 90:248–257. 2003.

20 

Jin Y, Tong DY, Chen JN, et al: Overexpression of osteopontin, αvβ3 and Pim-1 associated with prognostically important clinicopathologic variables in non-small cell lung cancer. PLoS One. 7:e485752012.

21 

Xuan SH, Zhou YG, Pan JQ, Zhu W and Xu P: Overexpression of integrin αv in the human nasopharyngeal carcinoma associated with metastasis and progression. Cancer Biomark. 13:323–328. 2013.

22 

Kawashima A, Tsugawa S, Boku A, et al: Expression of αv integrin family in gastric carcinomas: increased αvβ6 is associated with lymph node metastasis. Pathol Res Pract. 199:57–64. 2003.

23 

Vogetseder A, Thies S, Ingold B, et al: αv-Integrin isoform expression in primary human tumors and brain metastases. Int J Cancer. 133:2362–2371. 2013.

24 

Cruet-Hennequart S, Maubant S, Luis J, Gauduchon P, Staedel C and Dedhar S: αv integrins regulate cell proliferation through integrin-linked kinase (ILK) in ovarian cancer cells. Oncogene. 22:1688–1702. 2003.

25 

Wong NC, Mueller BM, Barbas CF, et al: αv integrins mediate adhesion and migration of breast carcinoma cell lines. Clin Exp Metastasis. 16:50–61. 1998.

26 

Samanna V, Wei H, Ego-Osuala D and Chellaiah MA: Alpha-V-dependent outside-in signaling is required for the regulation of CD44 surface expression, MMP-2 secretion, and cell migration by osteopontin in human melanoma cells. Exp Cell Res. 312:2214–2230. 2006. View Article : Google Scholar

27 

Khatib AM, Nip J, Fallavollita L, Lehmann M, Jensen G and Brodt P: Regulation of urokinase plasminogen activator/plasmin-mediated invasion of melanoma cells by the integrin vitronectin receptor αvβ3. Int J Cancer. 91:300–308. 2001.PubMed/NCBI

28 

Dutta A, Li J, Lu H, et al: Integrin αvβ6 promotes an osteolytic program in cancer cells by upregulating MMP2. Cancer Res. 74:1598–1608. 2014.

29 

Brooks PC, Strömblad S, Sanders LC, et al: Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell. 85:683–693. 1996.

30 

Hayashido Y, Shirasuna K, Sugiura T, Nakashima M and Matsuya T: Effect of dexamethasone on invasion of human squamous cell carcinoma cells into collagen gel. Cancer Lett. 108:81–86. 1996. View Article : Google Scholar : PubMed/NCBI

31 

Yamanaka T, Sakamoto A, Tanaka Y, et al: Isolation and serum-free culture of epithelial cells derived from epithelial rests of Malassez in human periodontal ligament. In Vitro Cell Dev Biol Anim. 36:548–553. 2000. View Article : Google Scholar : PubMed/NCBI

32 

Hood JD, Frausto R, Kiosses WB, Schwartz MA and Cheresh DA: Differential αv integrin-mediated Ras-ERK signaling during two pathways of angiogenesis. J Cell Biol. 162:933–943. 2003.

33 

Kobayashi-Sakamoto M, Isogai E, Hirose K and Chiba I: Role of αv integrin in osteoprotegerin-induced endothelial cell migration and proliferation. Microvasc Res. 76:139–144. 2008.

34 

Bianchi-Smiraglia A, Paesante S and Bakin AV: Integrin β5 contributes to the tumorigenic potential of breast cancer cells through the Src-FAK and MEK-ERK signaling pathways. Oncogene. 32:3049–3058. 2013.

35 

Natali PG, Hamby CV, Felding-Habermann B, et al: Clinical significance of αvβ3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions. Cancer Res. 57:1554–1560. 1997.

36 

Fabricius EM, Wildner GP, Kruse-Boitschenko U, Hoffmeister B, Goodman SL and Raguse JD: Immunohistochemical analysis of integrins αvβ3, αvβ5 and α5β1, and their ligands, fibrinogen, fibronectin, osteopontin and vitronectin, in frozen sections of human oral head and neck squamous cell carcinomas. Exp Ther Med. 2:9–19. 2011.

37 

Enns A, Korb T, Schlüter K, et al: αvβ5-integrin mediate early steps of metastasis formation. Eur J Cancer. 41:1065–1072. 2005.

38 

Hayashido Y, Urabe K, Yoshioka Y, Kitano H, Okamoto T and Matsuya T: Participation of fibroblasts in MMP-2 binding and activation on the surface of oral squamous cell carcinoma cells. Int J Oncol. 22:657–662. 2003.PubMed/NCBI

39 

Wang S and Basson MD: Integrin-linked kinase: a multi-functional regulator modulating extracellular pressure-stimulated cancer cell adhesion through focal adhesion kinase and AKT. Cell Oncol. 31:273–289. 2009.

40 

Cary LA, Han DC and Guan JL: Integrin-mediated signal transduction pathways. Histol Histopathol. 14:1001–1009. 1999.PubMed/NCBI

41 

Cabodi S, Di Stefano P, Leal Mdel P, et al: Integrins and signal transduction. Adv Exp Med Biol. 674:43–54. 2010. View Article : Google Scholar

42 

Huveneers S and Danen EH: Adhesion signaling-crosstalk between integrins, Src and Rho. J Cell Sci. 122:1059–1069. 2009. View Article : Google Scholar : PubMed/NCBI

43 

Metlapally R, Jobling AI, Gentle A and McBrien NA: Characterization of the integrin receptor subunit profile in the mammalian sclera. Mol Vis. 12:725–734. 2006.PubMed/NCBI

44 

Nemeth JA, Nakada MT, Trikha M, et al: Alpha-v integrins as therapeutic targets in oncology. Cancer Invest. 25:632–646. 2007. View Article : Google Scholar : PubMed/NCBI

45 

Webb DL, Conrad PJ, Ma L and Blue ML: Induction of mouse β integrin expression following transfection with human α4 chain. J Cell Biochem. 61:127–138. 1996.

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Hayashido Y, Kitano H, Sakaue T, Fujii T, Suematsu M, Sakurai S and Okamoto T: Overexpression of integrin αv facilitates proliferation and invasion of oral squamous cell carcinoma cells via mek/erk signaling pathway that is activated by interaction of integrin αvβ8 with type Ⅰ collagen. Int J Oncol 45: 1875-1882, 2014.
APA
Hayashido, Y., Kitano, H., Sakaue, T., Fujii, T., Suematsu, M., Sakurai, S., & Okamoto, T. (2014). Overexpression of integrin αv facilitates proliferation and invasion of oral squamous cell carcinoma cells via mek/erk signaling pathway that is activated by interaction of integrin αvβ8 with type Ⅰ collagen. International Journal of Oncology, 45, 1875-1882. https://doi.org/10.3892/ijo.2014.2642
MLA
Hayashido, Y., Kitano, H., Sakaue, T., Fujii, T., Suematsu, M., Sakurai, S., Okamoto, T."Overexpression of integrin αv facilitates proliferation and invasion of oral squamous cell carcinoma cells via mek/erk signaling pathway that is activated by interaction of integrin αvβ8 with type Ⅰ collagen". International Journal of Oncology 45.5 (2014): 1875-1882.
Chicago
Hayashido, Y., Kitano, H., Sakaue, T., Fujii, T., Suematsu, M., Sakurai, S., Okamoto, T."Overexpression of integrin αv facilitates proliferation and invasion of oral squamous cell carcinoma cells via mek/erk signaling pathway that is activated by interaction of integrin αvβ8 with type Ⅰ collagen". International Journal of Oncology 45, no. 5 (2014): 1875-1882. https://doi.org/10.3892/ijo.2014.2642
Copy and paste a formatted citation
x
Spandidos Publications style
Hayashido Y, Kitano H, Sakaue T, Fujii T, Suematsu M, Sakurai S and Okamoto T: Overexpression of integrin αv facilitates proliferation and invasion of oral squamous cell carcinoma cells via mek/erk signaling pathway that is activated by interaction of integrin αvβ8 with type Ⅰ collagen. Int J Oncol 45: 1875-1882, 2014.
APA
Hayashido, Y., Kitano, H., Sakaue, T., Fujii, T., Suematsu, M., Sakurai, S., & Okamoto, T. (2014). Overexpression of integrin αv facilitates proliferation and invasion of oral squamous cell carcinoma cells via mek/erk signaling pathway that is activated by interaction of integrin αvβ8 with type Ⅰ collagen. International Journal of Oncology, 45, 1875-1882. https://doi.org/10.3892/ijo.2014.2642
MLA
Hayashido, Y., Kitano, H., Sakaue, T., Fujii, T., Suematsu, M., Sakurai, S., Okamoto, T."Overexpression of integrin αv facilitates proliferation and invasion of oral squamous cell carcinoma cells via mek/erk signaling pathway that is activated by interaction of integrin αvβ8 with type Ⅰ collagen". International Journal of Oncology 45.5 (2014): 1875-1882.
Chicago
Hayashido, Y., Kitano, H., Sakaue, T., Fujii, T., Suematsu, M., Sakurai, S., Okamoto, T."Overexpression of integrin αv facilitates proliferation and invasion of oral squamous cell carcinoma cells via mek/erk signaling pathway that is activated by interaction of integrin αvβ8 with type Ⅰ collagen". International Journal of Oncology 45, no. 5 (2014): 1875-1882. https://doi.org/10.3892/ijo.2014.2642
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team